Online citations, reference lists, and bibliographies.
← Back to Search

The Evolution Of A Migraine Attack – A Review Of Recent Evidence

A. Charles
Published 2013 · Psychology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
A migraine attack is an extraordinarily complex brain event that takes place over hours to days. This review focuses on recent human studies that shed light on the evolution of a migraine attack. It begins with a constellation of premonitory symptoms that are associated with activation of the hypothalamus and may involve the neurotransmitter dopamine. Even in the premonitory phase, patients experience sensitivity to sensory stimuli, indicating that central sensitization is a primary phenomenon. The migraine attack progresses to a phase that in some patients includes aura, which involves changes in cortical function, blood flow, and neurovascular coupling. The aura phase overlaps with the headache phase, which is associated with further changes in blood flow and function of the brainstem, thalamus, hypothalamus, and cortex. Serotonin receptors, nitric oxide, calcitonin gene‐related peptide, pituitary adenylate cyclase‐activating polypeptide, and prostanoids are demonstrated specific chemical mediators of migraine based on therapeutic and triggered migraine studies. A number of migraine symptoms persist beyond resolution of headache into a postdromal phase, accompanied by persistent blood flow changes in several brain regions. Although these phases of migraine have substantial temporal, neurochemical, and anatomical overlap, each represents an important window onto the pathophysiology of migraine as well as a target for therapeutic intervention. A comprehensive approach to migraine requires an understanding of the entire range of mechanisms and resultant symptoms that occur throughout the evolution of an attack.
This paper references
10.1111/j.1468-2982.2007.01478.x
Dopamine and Migraine: Biology and Clinical Implications
S. Akerman (2007)
10.1111/j.1526-4610.2007.00842.x
The Hypothalamic Orexinergic System: Pain and Primary Headaches
P. Holland (2007)
10.3174/ajnr.A1115
Migraine Associated Cerebral Hyperperfusion with Arterial Spin-Labeled MR Imaging
J. Pollock (2008)
Dopamine involvement in the migraine attack.
M. Fanciullacci (2000)
10.1186/1129-2377-14-S1-P130
Migraine headache is present in the aura phase – a prospective study
J. Hansen (2013)
10.1093/brain/awp102
Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage
J. Dreier (2009)
10.1002/ana.22292
Evidence for a vascular factor in migraine
M. Asghar (2011)
10.1177/0333102410385581
Brainstem changes in 5-HT1A receptor availability during migraine attack
G. Demarquay (2011)
Premonitory symptoms in migraine: An electronic diary study
NJ Giffin (2003)
10.1016/j.annemergmed.2010.11.023
Metoclopramide for acute migraine: a dose-finding randomized clinical trial.
B. Friedman (2011)
10.1111/j.1468-2982.2006.01157.x
Premonitory and Resolution Symptoms in Migraine: A Prospective Study in 100 Unselected Patients
E. Quintela (2006)
10.1007/s00234-011-0946-z
Perfusion-weighted MR imaging in persistent hemiplegic migraine
I. Mourand (2011)
Dopamine involvement in the migraine
M Fanciullacci (2000)
10.1002/ANA.410280610
Timing and topography of cerebral blood flow, aura, and headache during migraine attacks
J. Olesen (1990)
Opening of the bloodbrain barrier preceding cortical edema in a severe attack of FHM type II. Neurology
JP Dreier (2005)
10.1038/nm0202-136
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model
H. Bolay (2002)
10.1136/jnnp.2009.190223
Photophobia in migraine: an interictal PET study of cortical hyperexcitability and its modulation by pain
N. Boulloche (2010)
10.1111/j.1468-2982.2005.01026.x
The Postdrome of the Acute Migraine Attack
L. Kelman (2006)
10.1046/J.1468-2982.1999.019008701.X
Perfusion Weighted Imaging During Migraine: Spontaneous Visual Aura and Headache
M. S. del Río (1999)
10.1073/pnas.071582498
Mechanisms of migraine aura revealed by functional MRI in human visual cortex
N. Hadjikhani (2001)
10.1016/j.jns.2009.06.009
Aphasic and visual aura with increased vasogenic leakage: An atypical migrainosus status
S. Lanfranconi (2009)
10.1111/j.1468-2982.2004.00858.x
Diffusion- and Perfusion-Weighted MR Imaging in Persistent Migrainous visual Disturbances
H. Jäger (2005)
10.1016/S1474-4422(10)70054-5
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial
R. Lipton (2010)
10.1007/s10140-012-1051-2
Susceptibility-weighted imaging and computed tomography perfusion abnormalities in diagnosis of classic migraine
C. Miller (2012)
10.1097/00002826-199702000-00004
Dopamine hypersensitivity in migraine: role of the apomorphine test.
R. Cerbo (1997)
10.1111/j.1526-4610.2007.00948.x
Diffusion MRI During Migraine With Aura Attack Associated With Diagnostic Microbubbles Injection in Subjects With Large PFO
L. Dinia (2007)
Dopamine and migraine. Neurology
SJ Peroutka (1997)
10.1212/WNL.49.3.650
Dopamine and migraine
S. Peroutka (1997)
10.1111/j.1526-4610.2010.01817.x
Key Concepts of Migraine Postdrome: A Qualitative Study to Develop a Post‐Migraine Questionnaire
D. Ng-Mak (2011)
10.1038/nn.2475
A neural mechanism for exacerbation of headache by light
R. Noseda (2010)
10.1212/WNL.51.5.1465
MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine
K. Welch (1998)
10.1016/j.pain.2004.05.007
Glyceryl trinitrate triggers premonitory symptoms in migraineurs
S. Afridi (2004)
10.1111/j.1468-2982.2008.01814.x
Migraine and the Hypothalamus
K. Alstadhaug (2009)
10.1345/aph.1Q255
Drug-Induced Yawning—A Review
E. Patatanian (2011)
10.1177/0333102410375512
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan – A randomised proof-of-concept trial
M. Ferrari (2010)
10.1111/j.1468-2982.2009.01854.x
The Prevalence of Premonitory Symptoms in Paediatric Migraine: A Questionnaire Study in 103 Children and Adolescents
J. Cuvellier (2009)
10.1046/j.1468-2982.1985.0504223.x
Warning Symptoms in Migraine: Characteristics and Therapeutic Implications
J. Waelkens (1985)
10.1177/0333102410370873
Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan
D. Nelson (2010)
10.1046/j.1468-2982.1984.0402085.x
Dopamine Blockade With Domperidone: Bridge Between Prophylactic and Abortive Treatment of Migraine? A Dose-Finding Study
J. Waelkens (1984)
10.1111/j.1468-2982.2007.01278.x
Treatment-Emergent CNS Symptoms Following Triptan Therapy are Part of The Attack
P. Goadsby (2007)
10.2169/INTERNALMEDICINE.48.2565
The middle meningial artery during a migraine attack: 3T magnetic resonance angiography study.
E. Nagata (2009)
10.1212/01.WNL.0000176298.63840.99
Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II
J. Dreier (2005)
10.1212/WNL.0b013e31823a0ceb
Pearls & Oy-sters: Dynamics of altered cerebral perfusion and neurovascular coupling in migraine aura
M. Wolf (2011)
Hypothalamic activation in spontaneous migraine
M Denuelle (2007)
10.1046/j.1468-2982.2000.00122.x
Habituation of visual and intensity dependence of auditory evoked cortical potentials tends to normalize just before and during the migraine attack.
Á. Judit (2000)
10.1136/jnnp-2011-300843
Neurovascular changes in prolonged migraine aura in FHM with a novel ATP1A2 gene mutation
T. Iizuka (2011)
10.1016/S0140-6736(95)91554-0
The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine
P. Tfelt-Hansen (1995)
10.1097/WCO.0b013e328337b884
What have we learnt from triggering migraine?
H. Schytz (2010)
Energy consumption and gait analysis in children with myelomeningocele.
M. Galli (2000)
10.1097/00002826-199102000-00008
Apomorphine-induced yawning in migraine patients: enhanced responsiveness.
O. Blin (1991)
10.1212/WNL.0b013e3182074a57
A PET study of photophobia during spontaneous migraine attacks
M. Denuelle (2010)
10.1212/01.wnl.0000314693.57386.f0
Migraine with aura associated with reversible sulcal hyperintensity in FLAIR
M. Gómez-Choco (2008)
10.1016/S1474-4422(12)70047-9
Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
M. Färkkilä (2012)
10.1161/STROKEAHA.107.488395
Probable Migraine With Visual Aura and Risk of Ischemic Stroke: The Stroke Prevention in Young Women Study
Leah R Macclellan (2007)
10.1016/S0306-4522(03)00570-0
Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input
P. Goadsby (2003)
10.1111/j.1468-2982.2009.02007.x
Migraine aura presenting as dysphasia with global cognitive dysfunction and abnormalities on perfusion CT
D. J. Nieuwkamp (2010)
10.1002/ANA.410430108
Perfusion‐weighted imaging defects during spontaneous migrainous aura
F. Michael Cutrer (1998)
10.1177/0333102409360828
Does single cortical spreading depression elicit pain behaviour in freely moving rats?
D. Akçali (2010)
10.1212/01.wnl.0000203646.05540.ec
Migraine with aura associated with reversible MRI abnormalities
S. Resnick (2006)
10.1016/J.ANNEMERGMED.2007.09.027
A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine.
B. Friedman (2008)
10.1093/brain/awn259
Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study.
A. Vandenbrink (2009)
10.1111/j.1526-4610.2004.04168.x
The Premonitory Symptoms (Prodrome): A Tertiary Care Study of 893 Migraineurs
L. Kelman (2004)
10.1212/WNL.58.8.1308-A
Hyperperfusion with vasogenic leakage by fMRI in migraine with prolonged aura.
M. Smith (2002)
10.1002/ana.21994
Thalamic sensitization transforms localized pain into widespread allodynia
R. Burstein (2010)
10.1111/j.1526-4610.2008.01183.x
Cortical Spreading Edema in Persistent Visual Migraine Aura
D. Bereczki (2008)
10.1001/ARCHNEUR.56.5.548
Functional MRI-BOLD of visually triggered headache in patients with migraine.
Y. Cao (1999)
Efficacy and tolerability of lasmiditan, a new oral 5-HT1F receptor agonist for the acute treatment of migraine: A phase II randomised, placebo-controlled, parallel-group dose ranging study
M Färkkila (2012)
10.1093/BRAIN/AWH416
A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate.
S. Afridi (2005)
10.1111/j.1526-4610.2010.01634.x
Partially Reversible Cortical Metabolic Dysfunction in Familial Hemiplegic Migraine With Prolonged Aura
E. Guedj (2010)
10.1111/j.1468-2982.2006.01195.x
The Prevalence of Premonitory Symptoms in Migraine: A Questionnaire Study in 461 Patients
G. Schoonman (2006)
10.1111/j.1526-4610.2011.01963.x
Hemiplegic Migraine Aura Begins With Cerebral Hypoperfusion: Imaging in the Acute Phase
J. B. Hansen (2011)
10.1111/j.1468-2982.2009.01843.x
Changes in Functional Vasomotor Reactivity in Migraine With Aura
M. Wolf (2009)
10.1186/1129-2377-14-S1-P113
Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura
M. Antonova (2013)
10.1016/S0304-3940(02)00940-0
Multimodal functional imaging of prolonged neurological deficits in a patient suffering from familial hemiplegic migraine
A. Gutschalk (2002)
10.1177/0333102412437390
The premonitory phase of migraine and migraine management
W. Becker (2013)
10.1111/j.1526-4610.2008.01184.x
Reversible Imaging Abnormalities Consistent With CSD During Migraine Without Aura Attack
F. D. Chalaupka (2008)
10.1111/j.1468-2982.2008.01623.x
Posterior Cerebral Hypoperfusion in Migraine Without Aura
M. Denuelle (2008)
10.1111/j.1526-4610.2007.00776.x
Hypothalamic Activation in Spontaneous Migraine Attacks
M. Denuelle (2007)
Pearls & oysters: Dynamics of altered cerebral perfusion and neurovascular coupling in migraine
ME Wolf (2011)
Midbrain activation in the premonitory phase of migraine: A H215O-positron emission tomography study
T Sprenger (2012)



This paper is referenced by
10.4274/npa.y7244
The Face of Chronic Migraine Which Has Started to be Clarified.
Zeynep Aydin Özemir (2013)
10.1016/j.preteyeres.2015.07.006
Clinical impact of migraine for the management of glaucoma patients
Bao N. Nguyen (2016)
10.1177/1073858413503711
Migraine Mistakes
D. Borsook (2014)
Microvasculature, the Trigeminal System and Migraine : A focus on female sex hormones
Khatera Ibrahimi (2015)
Increased risk of Bell pal sy in patient with migraine A longitudinal follow-up study
So Young Kim (2019)
10.1016/j.npep.2013.10.010
CGRP and migraine: Could PACAP play a role too?
E. Kaiser (2013)
10.1007/s11916-013-0373-4
Dietary Considerations in Migraine Management: Does a Consistent Diet Improve Migraine?
A. Finkel (2013)
10.3390/metabo10040164
Metabolomics in Central Sensitivity Syndromes
J. S. Miller (2020)
UPDATE IN DIAGNOSIS AND TREATMENT OF MIGRAINES
Sama Samir Mohammed (2017)
The role of New Zealand osteopaths in the care of people who experience migraine : a qualitative exploration
Kaspara Chaise (2017)
10.1016/J.NRL.2019.03.013
CGRP en migraña: de la fisiopatología a la terapéutica
S. Santos-Lasaosa (2019)
10.1186/1471-2318-13-126
Association between ischemic stroke and migraine in elderly Chinese: a case–control study
H. Li (2013)
Headache 2 The pathophysiology of migraine : implications for clinical management
Andrew Charles (2017)
10.1021/ACSPTSCI.8B00036
CGRP-based Migraine Therapeutics: How Might They Work, Why So Safe, and What Next?
A. Russo (2019)
10.1111/joor.12410
Headaches and myofascial temporomandibular disorders: overlapping entities, separate managements?
P. Conti (2016)
10.1201/9781315377315-19
Systematic review and meta-analysis
Jun-Il Yoo (2018)
10.2217/FNL-2016-0006
Toward mechanism-based treatment of migraine: spotlight on CGRP
P. Gazerani (2016)
10.1016/j.ncl.2013.11.004
Headaches and vasculitis.
D. Younger (2014)
10.34024/rnc.2013.v21.8196
Ansiedade e Depressão em Pacientes Migranosos
Deusvenir de Souza Carvalho (2013)
10.1007/978-3-319-78117-4_2
What Is Migraine
Thomas Muehlberger (2018)
10.1016/j.nrl.2017.09.014
The premonitory phase: A crucial stage in migraine.
A. Gago-Veiga (2017)
La migraine de l'enfant : étude descriptive d'une cohorte de patients suivis à l'hôpital des enfants et analyse de l'adhésion thérapeutique
M. Gougeon (2019)
10.1080/13696998.2018.1457533
Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective
R. Lipton (2018)
10.7861/clinmedicine.17-2-156
Mimics and chameleons in stroke
S. Anathhanam (2017)
10.1097/j.pain.0000000000001337
Peripherally administered calcitonin gene–related peptide induces spontaneous pain in mice: implications for migraine
Brandon J. Rea (2018)
10.4181/RNC.2013.21.689ED.2P
Ansiedade e Depressão em Pacientes Migranosos - Editorial
Deusvenir de Souza Carvalho (2013)
10.1007/s00417-020-04672-1
Impact of laser iridotomy on headache symptoms in angle-closure subjects
F. Teixeira (2020)
10.1016/j.jpain.2016.11.007
Transcriptomic Changes in Rat Cortex and Brainstem After Cortical Spreading Depression With or Without Pretreatment With Migraine Prophylactic Drugs.
C. Sintas (2017)
10.1097/MD.0000000000015764
Increased risk of Bell palsy in patient with migraine
S. Y. Kim (2019)
10.1186/s10194-015-0547-z
Migraine is associated with an increased risk for benign paroxysmal positional vertigo: a nationwide population-based study
C. Chu (2015)
10.1016/j.biochi.2019.03.023
Serotonin-estrogen interactions: What can we learn from pregnancy?
Andrée-Anne Hudon Thibeault (2019)
10.1111/head.12460
From Wakefulness to Sleep: Migraine and Hypnic Headache Association in a Series of 23 Patients
M. Ruiz (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar